Nanosponge: A Novel Nano Drug Carrier

Authors

  • Anmol Eldose Sigma Institute of Pharmacy, Vadodara, Gujarat, India
  • Parmar Twinkle Sigma Institute of Pharmacy, Vadodara, Gujarat, India
  • Shah Honey Sigma Institute of Pharmacy, Vadodara, Gujarat, India
  • Zala Twinkle Sigma Institute of Pharmacy, Vadodara, Gujarat, India
  • Hitesh Jain Sigma Institute of Pharmacy, Vadodara, Gujarat, India
  • Upadhyay Umesh Sigma Institute of Pharmacy, Vadodara, Gujarat, India

DOI:

https://doi.org/10.53555/nnpbs.v1i7.565

Keywords:

Nanosponge, Quasi-emulsion solvent diffusion, Resilency, Solvent method, Ultra soundAssisted synthesis

Abstract

Nanotechnology, a multi-disciplinary science has received considerable attention in the recent times in the discovery of new chemical entities, diagnosis and treatment of several diseases. Nano-medicine has developed many drug delivering systems like nanoparticles, nano-emulsions, nano-suspensions, nanosponges etc., to overcome the problems of bioavailability out of which nanosponge is an advanced drug delivery system which offers diverse advantages than the other available systems. Targeted drug delivery to specific sites is the significant problem which is being faced by the researchers. The development of new colloidal carrier called nanosponges has the potential to solve these problems. Nanosponge is a novel and emerging technology which offers controlled drug delivery for topical use. Nanosponges are solid, porous, biocompatible, and tiny in size with three dimensional structure and nanomeric cavity size which have unique ability to entrap wide variety of drugs. Nanosponges can be used as a carrier for biocatalysts in the delivery and release of enzymes, proteins, vaccines and antibodies. Nanosponges are porous polymeric delivery systems that are small spherical particles with large porous surface. The nanosponges have the ability to include either lipophilic or hydrophilic drugs and release them in a controlled and predictable manner at the target site. By controlling the ratio of polymer to the cross-linker the particle size and release rate can be modulated.

References

Vyas S, Khar RK (2008) Targeted and Controlled Drug Delivery- Novel Carrier Systems. Molecular Basis of Targeted Drug Delivery. CBS Publishers and Distributors. New Delhi, 38- 40

Trotta F, Cavalli R, Tumiatti W, Zerbinati O,Rogero C, Vallero R (2007) Ultrasound- Assisted synthesis of Cyclodextrin-based nanosponges. EP1, 786: 841

David F. Nanosponge drug delivery system more effective than direct injection. www.physorg.com 01.06.2010, accessed on 20.12.2011

Cavalli R, Trotta F and Tumiatti W (2006) Cyclodextrin-based Nanosponges for Drug Delivery. Journal of Inclusion Phenomena and Macro Chemistry, 56(1-2):209-213

Nacht S, Kantz M (1992) The Microsponge: A Novel Topical Programmable Delivery System: Topical Drug Delivery Systems. Edited by David W. O. and Anfon H. A., 42: 299-325

E.K Patel, RJ Oswal (2012) Nanosponge and Microsponges: A Novel Drug Delivery System International Journal of Research in Pharmacy and Chemistry, 2(2): 237-244

Leslie Z, Benet (2007) BCS and BDDCS. Bioavailability and Bioequivalence: Focus on Physiological Factors and Variability. Department of pharmaceutical sciences, University of California, San Francisco, USA

Renuka S, Roderick B, Kamla P (2011) Evaluation of Kinetics and Mechanism of Drug Release from Econazole nitrate Nanosponge Loaded Carbapol Hydrogel. Ind J Pham Edu Res, 45(1):25-31

NileshJ, Ruchi J, Navneet T, Brham PG, Deepak KJ (2010) Nanotechnology: A Safe and Effective Drug Delivery Systems. Asian Journal of Pharmaceutical and Clinical Research, 3(3), 159-165

Nacht S, Kantz M (1992) The microsponge: a novel topical programmable delivery system, In: Topical Drug Delivery Systems. David W.O and Anfon H.A (ED), 42

Delattre L, Delneuville I (1995) Biopharmaceutical aspects of the formulation of dermatological vehicles. J Eur Acad Derm Vener, 5:70

http://Sciencematters, Unimelb.edu.au/ 2011/05/nanosponges for targeted- cancer-treatment/visited on 12/10/2011

Sharma R, Roderick B, and Pathak K (2011) Evaluation of kinetics and mechanism of drugrelease from Econazole nitrate Nanosponge loaded carbopol Hydrogel. Indian J of Pharma Edu and research, 45(1):25-31

Cavalli R, Trotta F, Tumiatti V (2006) Cyclodextrin-based nanosponges for drug delivery. J Incl Phenom Macrocyl Chem , 56: 209- 213

Selvamuthukumar Subramanian et al (2012) Nanosponges: A Novel Class of Drug Delivery System– Review. J Pharm Pharma Sci, 15(1): 103 – 111

Geeta Yadav (2013) Nanosponges: A boon to the targeted drug delivery system (2013) Journal of Drug Delivery & Therapeutics, 3(4): 151-155

Uday B., Manvi FV, et.al (2013) Recent Advances in Nanosponges as Drug Delivery System. International Journal of Pharmaceutical Sciences and Nanotechnology, 6(1):1934-1944

Jilsha G, Vidya Viswanad (2013) Nanosponges: A Novel Approach of Drug Delivery System. Int. J. Pharm. Sci. Rev. Res, 19(2): 119-123

Embil K., and Nacht S.(1996) The microsponge delivery system atopical delivery system with reduced irritancy incorporating multiple triggering mechanisms for the releaseof actives. J Microencapsule, 13: 575–88

Mishra M.K., Shikhri M., Sharma R., and Goojar M.P. (2011) Optimization, formulation, development and characterization of Eudragit RS 100 loaded microsponges and subsequent colonic delivery. Int J of Drug Discovery And herbal Research, 1(1): 8-13

Martin A., Swarbrick J., and Cammarrata A. (2003) In: Physical Pharmacy-Physical Chemical Principles in Pharmaceutical Sciences, 3: 527

Emanuele A., and Dinarvand R. (1995), Preparation, Characterization and Drug Release from Thermoresponsive Microspheres. Int JPharm, 237:4

Kilicarslan M., and Baykara T. (2003) The effect of the drug/polymer ratio the properties of Verapamil HCl loaded microspheres. Int JPharm, 252:99–109

Barkai A., Pathak V., and BenitaS (1990) Polyacrylate (Eudragit retard) microspheres for oral controlled release of nifedipine, Formulation design and process optimization. Drug Dev Ind Pharm, 16:2057-2075

Wester R.,Patel R.,Natch S.,Leyden J.,Melendres J.,and Maibach H. (1991) Controlled release of benzoyl peroxide from a porous microsphere polymeric system can reduce topical irritancy, J. Am. Acad. Derm, 24:720-726

Ramnik S., Nitin B., Jyotsana M., Horemat S. (2010) Characterization of Cyclodextrin Inclusion complexes –A Review. J Pharm Sci Tech, 2(3):171-183

Maravajhala V., Papishetty S., Bandlapalli S. (2012) Nanotechnology in the development of drug delivery system, International journal of pharmaceutical sciences & research, 3(1): 84-96

Rao M. R., Bajaj A. N., Pardeshi A. A., Aghav S. S. (2012) Investigation of Nanoporous colloidal carrier for solubility enhancement of Cefpodoxime proxetil, Journal of pharmacy research, 5(5): 2496-2499

Ajay V, Preetam N, et,al (2014) Nanosponges: A Benefication For Novel Drug Delivery, International Journal of Pharm. Tech Research, 6(1):11-20

Flowerlet Mathew, et.al (2014) A Review on Targeted Drug Delivery through Nanosponge, International Journal of Universal Pharmacy and Bio Sciences 3(4):227-47

Zuruzi S., MacDonald N.C., Moskovits M., and Kolmakov A. (2007) Metal oxide "nanosponges" as chemical sensors: Highly sensitive detection of hydrogen using nanosponge titania; Angewandte Chemie, International Edition, 46 (23): 4298-4301

Swaminathan S., Vavia P.R., Trotta F. (2007) Formulation of beta cyclodextrins based nanosponges of itraconazole. J Incl Phenom Macro Chem., 57:89-94

Gilardi G., Trota F., Cavalli R., Ferruti P., Ranucc iE., Di Nardo G., Roggero C., Tumiatti V. (2009) Cyclodextrin nanosponges as carrier forbiocatalysts , and in the delivery and release of enzymes, proteins, vaccines and antibodies, WO2009149883 A1

Wong V.N., Fernando G., Wagner A.R., Zhang J,Kinsel G.R., Zauscher S., Dyer D.J. (2009) Separation of peptides with polyionic nanosponges for MALDIM Sanalysis. Langmuir,25(3):1459-65

Ansari K.A., Torne S., Vavia P.R., Trotta F., Cavalli R. (2011) Cyclodextrin - Based Nanosponges for Delivery of Resveratrol: In Vitro Characterization, Stability, Cytotoxicity and Permeation Study, AAPS Pharm Sci Tech,12(1): 279-86

Rosalba M, Roberta C, Roberto F, Chiara D, Piergiorgio P, Leigh E, Li S, Roberto P (2011). Antitumor activity of nanosponge-encapsulated Camptotechin in human prostate tumors. Cancer Res, 71:4431

Downloads

Published

2015-07-31

How to Cite

Eldose, A., Twinkle, P., Honey, S., Twinkle, Z., Jain, H., & Umesh, U. (2015). Nanosponge: A Novel Nano Drug Carrier. Journal of Advance Research in Pharmacy and Biological Science (ISSN 2208-2360) , 1(7), 01-06. https://doi.org/10.53555/nnpbs.v1i7.565